Atlas Trials

Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy

Clinical trial NCT04676386 · TERMINATED

Trial details

NCT number
NCT04676386
Sponsor
Addario Lung Cancer Medical Institute
Status
TERMINATED
Study type
OBSERVATIONAL
NSCLC Stage IVNSCLC, Stage IIIC
Start date
2021-02-01
Primary completion
2023-12-30
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.